A Single‐lead ECG algorithm to differentiate right from left manifest accessory pathways: A reappraisal of the P‐Delta interval
Journal of Cardiovascular Electrophysiology · 2023
DOI: 10.1111/jce.15818 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2023. Verfasst von Hussam Ali und 11 weiteren Autor:innen. Beteiligte Einrichtung: Arrhythmia & Electrophysiology Center, IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy. Hauptthemen laut MEDLINE: Catheter Ablation, Accessory Atrioventricular Bundle, Wolff-Parkinson-White Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
Despite numerous ECG algorithms being developed to localize the site of manifest accessory pathways (AP), they often require stepwise multiple‐lead analysis with variable accuracy, limitations, and reproducibility. The study aimed to develop a single‐lead ECG algorithm incorporating the P‐Delta interval (PDI) as an adjunct criterion to discriminate between right and left manifest AP.
Methods
Consecutive WPW patients undergoing electrophysiological study (EPS) were retrospectively recruited and split into a derivation and validation group (1:1 ratio). Sinus rhythm ECG analysis in lead V1 was performed by three independent investigators blinded to the EPS results. Conventional ECG parameters and PDI were assessed through the global cohort.
Results
A total of 140 WPW patients were included (70 for each group). A score‐based, single‐lead ECG algorithm was developed through derivation analysis incorporating the PDI, R/S ratio, and QRS onset polarity in lead V1. The validation group analysis confirmed the proposed algorithm's high accuracy (95%), which was superior to the previous ones in predicting the AP side ( p < 0.05). A score of ≤+1 was 96.5% accurate in predicting right AP while a score of ≥+2 was 92.5% accurate in predicting left AP. The new algorithm maintained optimal performance in specific subgroups of the global cohort showing an accuracy rate of 90%, 92%, and 96% in minimal pre‐excitation, posteroseptal AP, and pediatric patients, respectively.
Conclusions
A novel single‐lead ECG algorithm incorporating the PDI interval with previous conventional criteria showed high accuracy in differentiating right from left manifest AP comprising pediatric and minimal pre‐excitation subgroups in the current study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Arrhythmia & Electrophysiology Center, IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
- Department of Clinical and Molecular Medicine, Division of Cardiology, St. Andrea Hospital, Sapienza University, Rome, Italy.
- Cardiovascular Department, Assiut University, Assiut, Egypt.
ORCID-Profile: Hussam Ali, Pietro Francia, Riccardo Cappato
Zitieren
APA
Ali, H., De Lucia, C., Cristiano, E., Lupo, P., Foresti, S., De Ambroggi, G., Turturiello, D., Paganini, E. M., Bessi, R., Farghaly, A. A. A., Francia, P., & Cappato, R. (2023). A Single‐lead ECG algorithm to differentiate right from left manifest accessory pathways: A reappraisal of the P‐Delta interval. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.15818
Vancouver
Ali H, De Lucia C, Cristiano E, Lupo P, Foresti S, De Ambroggi G, et al. A Single‐lead ECG algorithm to differentiate right from left manifest accessory pathways: A reappraisal of the P‐Delta interval. Journal of Cardiovascular Electrophysiology. 2023. doi:10.1111/jce.15818
BibTeX
@article{Ali2023,
author = {Ali, Hussam and De Lucia, Carmine and Cristiano, Ernesto and Lupo, Pierpaolo and Foresti, Sara and De Ambroggi, Guido and Turturiello, Dario and Paganini, Edoardo Maria and Bessi, Riccardo and Farghaly, Ahmad Abdelrady Abdelsalam and Francia, Pietro and Cappato, Riccardo},
title = {A Single‐lead ECG algorithm to differentiate right from left manifest accessory pathways: A reappraisal of the P‐Delta interval},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2023},
doi = {10.1111/jce.15818}
}
EUVIMED